Jihong Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jihong Hu has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
Li Wang
Affiliation College of Public Health, Gansu University of Chinese Medicine, Lanzhou, China
5 shared publications- Bin Luo
Lanzhou University
4 shared publications Ruoyi Lei
Institute of Occupational Health and Environmental Health, School of Public Health, Lanzhou University, Lanzhou, Gansu, 730000, China
4 shared publicationsBaode Xue
Institute of Occupational Health and Environmental Health, School of Public Health, Lanzhou University, Lanzhou, Gansu, 730000, China
3 shared publicationsCe Liu
Institute of Occupational Health and Environmental Health, School of Public Health, Lanzhou University, Lanzhou, Gansu, 730000, China
3 shared publicationsLiangjia Cao
College of Public Health, Gansu University of Chinese Medicine, Lanzhou, People’s Republic of China
3 shared publications
Latest Publications
- Open Access
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331486
Association between lactate-to-albumin ratio and 28-day ICU mortality in pediatric severe pneumonia patients
Introduction: The lactate-to-albumin ratio (LAR) has emerged as a promising prognostic biomarker in critical care, reflecting both metabolic dysfunction and inflammatory status. However, its prognostic value in pediatric severe pneumonia remains underexplored. This study aimed to investigate the association between LAR and 28-day ICU mortality in pediatric severe pneumonia patients using data from the Paediatric Intensive Care database. Methods: A retrospective cohort study was conducted involving 617 pediatric severe pneumonia patients admitted to the ICU between 2010 and 2018. LAR was calculated as the ratio of lactate (mmol/L) to albumin (g/dL). The primary outcome was 28-day ICU mortality. Cox proportional hazards regression models were used to assess the relationship between LAR and mortality, with restricted cubic splines (RCS) employed to explore potential nonlinear associations. Subgroup analyses were performed based on age, sex, and oxygenation status. Results: A significant linear relationship was observed between LAR and 28-day ICU mortality. Each unit increase in log (LAR) was associated with a 2.51-fold higher mortality risk (HR 2.51, 95% CI: 1.73, 3.65; P < 0.001). Kaplan-Meier analysis confirmed that patients in the highest LAR tertile had significantly lower survival probabilities compared to those in the lowest tertile (log-rank P < 0.001). Subgroup analyses revealed consistent associations across age, sex, and oxygenation status, with no significant interactions (all P for interaction>0.05). Conclusions: Higher LAR levels are independently associated with increased 28-day ICU mortality in pediatric severe pneumonia patients, demonstrating a linear relationship. These findings highlight LAR as a valuable prognostic tool for early risk stratification and clinical decision-making in this population. Further multicenter studies are needed to validate these results and explore interventions targeting LAR reduction to improve outcomes. Trial registration: Not applicable.
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331486
Open AccessAssociation between lactate-to-albumin ratio and 28-day ICU mortality in pediatric severe pneumonia patients
Introduction: The lactate-to-albumin ratio (LAR) has emerged as a promising prognostic biomarker in critical care, reflecting both metabolic dysfunction and inflammatory status. However, its prognostic value in pediatric severe pneumonia remains underexplored. This study aimed to investigate the association between LAR and 28-day ICU mortality in pediatric severe pneumonia patients using data from the Paediatric Intensive Care database. Methods: A retrospective cohort study was conducted involving 617 pediatric severe pneumonia patients admitted to the ICU between 2010 and 2018. LAR was calculated as the ratio of lactate (mmol/L) to albumin (g/dL). The primary outcome was 28-day ICU mortality. Cox proportional hazards regression models were used to assess the relationship between LAR and mortality, with restricted cubic splines (RCS) employed to explore potential nonlinear associations. Subgroup analyses were performed based on age, sex, and oxygenation status. Results: A significant linear relationship was observed between LAR and 28-day ICU mortality. Each unit increase in log (LAR) was associated with a 2.51-fold higher mortality risk (HR 2.51, 95% CI: 1.73, 3.65; P < 0.001). Kaplan-Meier analysis confirmed that patients in the highest LAR tertile had significantly lower survival probabilities compared to those in the lowest tertile (log-rank P < 0.001). Subgroup analyses revealed consistent associations across age, sex, and oxygenation status, with no significant interactions (all P for interaction>0.05). Conclusions: Higher LAR levels are independently associated with increased 28-day ICU mortality in pediatric severe pneumonia patients, demonstrating a linear relationship. These findings highlight LAR as a valuable prognostic tool for early risk stratification and clinical decision-making in this population. Further multicenter studies are needed to validate these results and explore interventions targeting LAR reduction to improve outcomes. Trial registration: Not applicable.
- Open Access
- 10 September 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 44, 102244
The multifaceted impact of a high-salt environment on the immune system and its contribution to salt-sensitive hypertension
- 10 September 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 44, 102244
Open AccessThe multifaceted impact of a high-salt environment on the immune system and its contribution to salt-sensitive hypertension
- Open Access
- 2 July 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-14
Gender differences in drug-induced precocious puberty: a real-world analysis of adverse event reports from the FDA FAERS database (2004–2024)
Precocious puberty (PP) is the early onset of secondary sexual characteristics before the typical age of puberty, which can be caused by hormonal imbalances or external factors, such as medications. Drug-induced precocious puberty (DIPP) has become a growing concern, particularly in pediatric populations. However, the impact of gender differences on DIPP risk and the challenges in drug safety assessments have not been fully explored. To investigate gender-specific differences in the occurrence of drug-induced precocious puberty (DIPP) and identify potential risk signals related to medication use, utilizing data from the U.S. FDA Adverse Event Reporting System (FAERS). Data from the FAERS database (2004–2024) were used to identify adverse event reports related to drug-induced precocious puberty. Disproportionality analysis (DPA) was applied to detect potential signals of DIPP. The analysis considered demographic variables, including drug, age, gender, weight, indications, and reporting country. Only the most recent report for each unique “caseid” was retained. A total of 529 reports of DIPP were identified, with a significant increase in reports from 2004 to 2024. The number of reports rose from 9 in 2004 to 53 in 2024, with an average of 40 reports per year from 2018 to 2024. The most frequently implicated drugs were testosterone (N = 88), somatropin (N = 52), and methylphenidate (N = 49). Drugs with the highest Reporting Odds Ratios (RORs) included mitotane (ROR = 220.35), mecasermin (ROR = 145.42), and clomifene (ROR = 141.35). Gender differences were observed, with 56.9% of reports from females and 36.3% from males. The majority of reports came from developed countries, with the U.S. contributing 50.47% of cases. The median time to adverse event occurrence was 238 days, with males showing a median induction time of 192.5 days and females at 242 days, though no statistically significant difference in induction time between males and females was found (p > 0.05). Drug-induced precocious puberty presents a significant clinical concern, particularly in pediatric populations. Gender-specific differences in drugs associated with precocious puberty highlight the need for personalized drug safety assessments. Key drugs associated with DIPP, but not listed as risk factors in labeling, underscore the importance of long-term monitoring. Further research is necessary to explore the mechanisms behind gender differences and enhance drug safety strategies, particularly for children and adolescents.
- 2 July 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-14
Open AccessGender differences in drug-induced precocious puberty: a real-world analysis of adverse event reports from the FDA FAERS database (2004–2024)
Precocious puberty (PP) is the early onset of secondary sexual characteristics before the typical age of puberty, which can be caused by hormonal imbalances or external factors, such as medications. Drug-induced precocious puberty (DIPP) has become a growing concern, particularly in pediatric populations. However, the impact of gender differences on DIPP risk and the challenges in drug safety assessments have not been fully explored. To investigate gender-specific differences in the occurrence of drug-induced precocious puberty (DIPP) and identify potential risk signals related to medication use, utilizing data from the U.S. FDA Adverse Event Reporting System (FAERS). Data from the FAERS database (2004–2024) were used to identify adverse event reports related to drug-induced precocious puberty. Disproportionality analysis (DPA) was applied to detect potential signals of DIPP. The analysis considered demographic variables, including drug, age, gender, weight, indications, and reporting country. Only the most recent report for each unique “caseid” was retained. A total of 529 reports of DIPP were identified, with a significant increase in reports from 2004 to 2024. The number of reports rose from 9 in 2004 to 53 in 2024, with an average of 40 reports per year from 2018 to 2024. The most frequently implicated drugs were testosterone (N = 88), somatropin (N = 52), and methylphenidate (N = 49). Drugs with the highest Reporting Odds Ratios (RORs) included mitotane (ROR = 220.35), mecasermin (ROR = 145.42), and clomifene (ROR = 141.35). Gender differences were observed, with 56.9% of reports from females and 36.3% from males. The majority of reports came from developed countries, with the U.S. contributing 50.47% of cases. The median time to adverse event occurrence was 238 days, with males showing a median induction time of 192.5 days and females at 242 days, though no statistically significant difference in induction time between males and females was found (p > 0.05). Drug-induced precocious puberty presents a significant clinical concern, particularly in pediatric populations. Gender-specific differences in drugs associated with precocious puberty highlight the need for personalized drug safety assessments. Key drugs associated with DIPP, but not listed as risk factors in labeling, underscore the importance of long-term monitoring. Further research is necessary to explore the mechanisms behind gender differences and enhance drug safety strategies, particularly for children and adolescents.
- Open Access
- 13 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Sex difference in the relationship between 24-h sodium–potassium ratio and prevalence of metabolic syndromes: a cross-sectional study
Maintaining a balanced ratio between sodium and potassium intake is one of the most important dietary and lifestyle factors in the development of metabolic syndrome (MetS), but available evidence is still limited, particularly when using urine samples to estimate this ratio. We aim to evaluate the associations between the 24-h urinary sodium–potassium ratio (24hUNa/KE) and MetS risk through a large health check-up program in China. This cross-sectional study analyzed health check-up data from 59,292 participants at the Third Xiangya Hospital’s Department of Health Management in Changsha, China, from 2018 to 2021. Each participant gave one fasting urine sample to analyze sodium, potassium, and creatinine levels during the check-up. The Kawasaki formula estimated 24-h urinary sodium (24hUNaE) and potassium excretion (24hUKE), with the 24hUNa/KE ratio calculated by dividing 24hUNaE by 24hUKE. The prevalence of MetS was found to be 19.27%. Notably, the overall MetS prevalence was higher in men (28.08%) than in women (7.83%). In women, MetS prevalence increased from 6.35 to 10.30% across the lowest to highest 24hUNa/KE quartiles. A significant increase in MetS prevalence was associated with each standard deviation increase in 24hUNa/KE (adjusted odds ratio [AOR], 1.03; 95% confidence interval [CI] 1.01–1.06), particularly for central obesity (AOR, 1.04; 95% CI 1.02–1.06) and elevated blood pressure (AOR, 1.20; 95% CI 1.17–1.22). In women, a one standard deviation increase in the 24hUNa/KE ratio raised the risk of MetS by 9% (AOR, 1.09; 95% CI 1.05–1.14), but no significant link was found in men. A strong positive link exists between 24hUNa/KE and MetS and its components, especially central obesity and high blood pressure, with a more significant effect in women.
- 13 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessSex difference in the relationship between 24-h sodium–potassium ratio and prevalence of metabolic syndromes: a cross-sectional study
Maintaining a balanced ratio between sodium and potassium intake is one of the most important dietary and lifestyle factors in the development of metabolic syndrome (MetS), but available evidence is still limited, particularly when using urine samples to estimate this ratio. We aim to evaluate the associations between the 24-h urinary sodium–potassium ratio (24hUNa/KE) and MetS risk through a large health check-up program in China. This cross-sectional study analyzed health check-up data from 59,292 participants at the Third Xiangya Hospital’s Department of Health Management in Changsha, China, from 2018 to 2021. Each participant gave one fasting urine sample to analyze sodium, potassium, and creatinine levels during the check-up. The Kawasaki formula estimated 24-h urinary sodium (24hUNaE) and potassium excretion (24hUKE), with the 24hUNa/KE ratio calculated by dividing 24hUNaE by 24hUKE. The prevalence of MetS was found to be 19.27%. Notably, the overall MetS prevalence was higher in men (28.08%) than in women (7.83%). In women, MetS prevalence increased from 6.35 to 10.30% across the lowest to highest 24hUNa/KE quartiles. A significant increase in MetS prevalence was associated with each standard deviation increase in 24hUNa/KE (adjusted odds ratio [AOR], 1.03; 95% confidence interval [CI] 1.01–1.06), particularly for central obesity (AOR, 1.04; 95% CI 1.02–1.06) and elevated blood pressure (AOR, 1.20; 95% CI 1.17–1.22). In women, a one standard deviation increase in the 24hUNa/KE ratio raised the risk of MetS by 9% (AOR, 1.09; 95% CI 1.05–1.14), but no significant link was found in men. A strong positive link exists between 24hUNa/KE and MetS and its components, especially central obesity and high blood pressure, with a more significant effect in women.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 19, 73-86
The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma
Bronchial asthma is a complex and heterogeneous disease with ongoing airway inflammation and increased airway responsiveness. Key characteristics of the disease include persistent airway inflammation, airway hyperresponsiveness, and airway remodeling. Asthma’s chronic and recurrent characteristics contribute to airway remodeling and inflammation, which can exacerbate lung damage. Presently, inflammation is predominantly managed with corticosteroids, yet there is a notable absence of treatments specifically addressing airway remodeling. The phosphoinositide 3-kinase (PI3K) signaling pathway is integral to the processes of inflammation, airway remodeling, and immune responses. Pharmacological agents targeting this pathway are currently undergoing clinical evaluation. This review elucidates the role of PI3K in the immune responses, airway inflammation, and remodeling associated with asthma, examining its underlying mechanisms. Furthermore, we synthesize the existing literature on the therapeutic potential of PI3K inhibitors for asthma management, emphasizing immune modulation, airway inflammation, and remodeling, including drug development and ongoing clinical trials. Lastly, we explore how various PI3K-targeted therapies may enhance efficacy and improve tolerance.
- 1 March 2025
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 19, 73-86
Open AccessThe Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma
Bronchial asthma is a complex and heterogeneous disease with ongoing airway inflammation and increased airway responsiveness. Key characteristics of the disease include persistent airway inflammation, airway hyperresponsiveness, and airway remodeling. Asthma’s chronic and recurrent characteristics contribute to airway remodeling and inflammation, which can exacerbate lung damage. Presently, inflammation is predominantly managed with corticosteroids, yet there is a notable absence of treatments specifically addressing airway remodeling. The phosphoinositide 3-kinase (PI3K) signaling pathway is integral to the processes of inflammation, airway remodeling, and immune responses. Pharmacological agents targeting this pathway are currently undergoing clinical evaluation. This review elucidates the role of PI3K in the immune responses, airway inflammation, and remodeling associated with asthma, examining its underlying mechanisms. Furthermore, we synthesize the existing literature on the therapeutic potential of PI3K inhibitors for asthma management, emphasizing immune modulation, airway inflammation, and remodeling, including drug development and ongoing clinical trials. Lastly, we explore how various PI3K-targeted therapies may enhance efficacy and improve tolerance.
- 1 March 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (3) , 532-541
Validation Status of Electronic Sphygmomanometers in China: A National Survey
BACKGROUND: Although the information on the validation status of electronic sphygmomanometer (ES) devices in use in health care institutions and households is much more clinically relevant than that of ES models available on the market, it remains insufficient. METHODS: A national survey was conducted across all administrative regions of mainland China to assess the validation status of ESs. Fifty-eight cities were selected with stratification by municipality, provincial capital, and other cities, and health care institutions and households in each city were chosen by convenience to identify ES devices in use according to the study protocol. Information on devices’ model, type, was collected. The validation status of each device was ascertained through searching international online registries of its models. RESULTS: A total of 3230 ES devices (1924 from health care institutions and 1306 from households), encompassing 498 ES models, were actually selected. The weighted proportion of accuracy-validated devices was significantly higher in health care institutions (33.9% [95% CI, 31.8–36.0%]) compared with households (23.0% [95% CI, 20.8–25.4%]; P <0.001), and both exceeded the proportions for models (17.7% [95% CI, 13.7–22.6%] and 12.5% [95% CI, 9.5–16.3%], respectively). Regional economic development, device type, and years in use were associated with the proportion of accuracy-validated devices. Notably, 8.8% of devices used in secondary hospitals were wrist type. CONCLUSIONS: The accuracy validation status of ESs in China in the number of devices in use shows a more favorable situation than that in the number of models but remains low and concerning. Policies are urgently needed to promote the widespread adoption of accuracy-validated models among all users.
- 1 March 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (3) , 532-541
Validation Status of Electronic Sphygmomanometers in China: A National Survey
BACKGROUND: Although the information on the validation status of electronic sphygmomanometer (ES) devices in use in health care institutions and households is much more clinically relevant than that of ES models available on the market, it remains insufficient. METHODS: A national survey was conducted across all administrative regions of mainland China to assess the validation status of ESs. Fifty-eight cities were selected with stratification by municipality, provincial capital, and other cities, and health care institutions and households in each city were chosen by convenience to identify ES devices in use according to the study protocol. Information on devices’ model, type, was collected. The validation status of each device was ascertained through searching international online registries of its models. RESULTS: A total of 3230 ES devices (1924 from health care institutions and 1306 from households), encompassing 498 ES models, were actually selected. The weighted proportion of accuracy-validated devices was significantly higher in health care institutions (33.9% [95% CI, 31.8–36.0%]) compared with households (23.0% [95% CI, 20.8–25.4%]; P <0.001), and both exceeded the proportions for models (17.7% [95% CI, 13.7–22.6%] and 12.5% [95% CI, 9.5–16.3%], respectively). Regional economic development, device type, and years in use were associated with the proportion of accuracy-validated devices. Notably, 8.8% of devices used in secondary hospitals were wrist type. CONCLUSIONS: The accuracy validation status of ESs in China in the number of devices in use shows a more favorable situation than that in the number of models but remains low and concerning. Policies are urgently needed to promote the widespread adoption of accuracy-validated models among all users.
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 2583-2600
Screening and Validation of Potential Biomarkers of Immune Cells in Childhood Asthma Patients via Mendelian Randomization and Machine Learning
Purpose: Asthma is one of the most common chronic respiratory diseases affecting children, and there is currently no clear remedy. Immune cells play a key role in childhood asthma. Therefore, a deeper investigation of the correlation between immune cells and childhood asthma could lead to a better understanding of asthma’s origin, the identification of potential treatment targets, and the development of personalized treatment strategies. Patients and Methods: We used a two-sample Mendelian randomization (MR) analysis to investigate the possible causal relationship between childhood asthma and a total of 731 immune cells, including B cell (190), Maturation stages of T cell (79), Monocyte (43), Myeloid cell (64), TBNK (124), Treg (167), and CDC (64). LASSO logistic regression and SVM algorithms were used to identify key genes associated with childhood asthma. Specific signaling pathways associated with these key genes were further explored through gene set variation analysis (GSVA) and gene set enrichment analysis (GSEA). Subsequently, the four key genes FCGR3A, TCTN3, ALOX5, and IL4R were verified in an established asthma mouse model using quantitative real-time PCR and Western blotting. Results: MR analysis showed that 60 immune cells were associated with childhood asthma, of which 32 were associated with high risk and 28 were associated with low risk. LASSO logistic regression and SVM algorithm identified six key genes that affect childhood asthma as ATF4, FCGR3A, GAS5, MGAT3, TAB1, and TCTN3. In addition, four genes, FCGR3A, TCTN3, ALOX5, and IL4R, were verified through animal experiments. Conclusion: Our findings confirmed that immune cells contribute to childhood asthma, highlighting the importance of key genes in the role of the immune microenvironment in this disease. These insights provide a new path for the exploration of the biological underpinnings of childhood asthma and the development of early intervention therapies.
- 1 February 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 2583-2600
Open AccessScreening and Validation of Potential Biomarkers of Immune Cells in Childhood Asthma Patients via Mendelian Randomization and Machine Learning
Purpose: Asthma is one of the most common chronic respiratory diseases affecting children, and there is currently no clear remedy. Immune cells play a key role in childhood asthma. Therefore, a deeper investigation of the correlation between immune cells and childhood asthma could lead to a better understanding of asthma’s origin, the identification of potential treatment targets, and the development of personalized treatment strategies. Patients and Methods: We used a two-sample Mendelian randomization (MR) analysis to investigate the possible causal relationship between childhood asthma and a total of 731 immune cells, including B cell (190), Maturation stages of T cell (79), Monocyte (43), Myeloid cell (64), TBNK (124), Treg (167), and CDC (64). LASSO logistic regression and SVM algorithms were used to identify key genes associated with childhood asthma. Specific signaling pathways associated with these key genes were further explored through gene set variation analysis (GSVA) and gene set enrichment analysis (GSEA). Subsequently, the four key genes FCGR3A, TCTN3, ALOX5, and IL4R were verified in an established asthma mouse model using quantitative real-time PCR and Western blotting. Results: MR analysis showed that 60 immune cells were associated with childhood asthma, of which 32 were associated with high risk and 28 were associated with low risk. LASSO logistic regression and SVM algorithm identified six key genes that affect childhood asthma as ATF4, FCGR3A, GAS5, MGAT3, TAB1, and TCTN3. In addition, four genes, FCGR3A, TCTN3, ALOX5, and IL4R, were verified through animal experiments. Conclusion: Our findings confirmed that immune cells contribute to childhood asthma, highlighting the importance of key genes in the role of the immune microenvironment in this disease. These insights provide a new path for the exploration of the biological underpinnings of childhood asthma and the development of early intervention therapies.
- Open Access
- 31 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0310550
Prevalence of lumbar disc herniation and its associated factors: A cross-sectional study in Gansu
Background and objective: The prevalence rate of LDH and its influencing factors in Gansu is unclear. This study aims to analyze the prevalence of LDH and influencing factors in Gansu. Methods: A stratified multi-stage random sampling method was used to obtain representative samples of residents more than 18 years old from 3500m altitude sites in Gansu, China, in June 2022 to August 2022. A unified questionnaire was used for the investigation. Results: The total number of people surveyed was 4545, with a prevalence rate of 22.77% for LDH. LDH prevalence differed by latitude, city, age, sex, nationality, education, marital status, income, drinking habits, residence duration, physical activity, exercise intensity, health status (including hypertension, diabetes, CHD, chronic infection, and tumors) (all P <0.05). Logistic regression showed higher LDH risk at high (OR = 2.250) and middle latitudes (OR = 2.551), among males (OR = 0.808), ages 35-49 (OR = 1.530) and 50-64 (OR = 1.991), Tibetans (OR = 1.533) and Hui (OR = 0.557), alcohol consumers (OR = 0.696), those with moderate (OR = 0.742) and mild physical activity (OR = 0.840), cadres (OR = 0.46), workers (OR = 1.568), farmers/herdsmen (OR = 1.840), married individuals (OR = 2.239), residents for ≥36 months (OR = 0.618), annual income ≥50,000 yuan (OR = 1.246), central obesity (OR = 1.399), and those with tumors (OR = 3.953), hypertension (unknown, OR = 1.817), diabetes (yes, OR = 0.529, unknown, OR = 0.565), CHD (unknown, OR = 1.404), and osteoporosis (unknown, OR = 1.404). Conclusion: The prevalence of LDH was high, varying significantly with latitude, gender, and nationality, indicating potential lifestyle and demographic influences in Gansu.
- 31 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0310550
Open AccessPrevalence of lumbar disc herniation and its associated factors: A cross-sectional study in Gansu
Background and objective: The prevalence rate of LDH and its influencing factors in Gansu is unclear. This study aims to analyze the prevalence of LDH and influencing factors in Gansu. Methods: A stratified multi-stage random sampling method was used to obtain representative samples of residents more than 18 years old from 3500m altitude sites in Gansu, China, in June 2022 to August 2022. A unified questionnaire was used for the investigation. Results: The total number of people surveyed was 4545, with a prevalence rate of 22.77% for LDH. LDH prevalence differed by latitude, city, age, sex, nationality, education, marital status, income, drinking habits, residence duration, physical activity, exercise intensity, health status (including hypertension, diabetes, CHD, chronic infection, and tumors) (all P <0.05). Logistic regression showed higher LDH risk at high (OR = 2.250) and middle latitudes (OR = 2.551), among males (OR = 0.808), ages 35-49 (OR = 1.530) and 50-64 (OR = 1.991), Tibetans (OR = 1.533) and Hui (OR = 0.557), alcohol consumers (OR = 0.696), those with moderate (OR = 0.742) and mild physical activity (OR = 0.840), cadres (OR = 0.46), workers (OR = 1.568), farmers/herdsmen (OR = 1.840), married individuals (OR = 2.239), residents for ≥36 months (OR = 0.618), annual income ≥50,000 yuan (OR = 1.246), central obesity (OR = 1.399), and those with tumors (OR = 3.953), hypertension (unknown, OR = 1.817), diabetes (yes, OR = 0.529, unknown, OR = 0.565), CHD (unknown, OR = 1.404), and osteoporosis (unknown, OR = 1.404). Conclusion: The prevalence of LDH was high, varying significantly with latitude, gender, and nationality, indicating potential lifestyle and demographic influences in Gansu.
- Open Access
- 19 September 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1399662
The effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015–2019)
Background: Lanzhou is the largest heavy industrial city in northwest China and it is a typical geographical valley-like city. However, there are few studies on the relationship between air pollutants and COPD, and their respective sample sizes are small, resulting in inconsistent results. The aim of this study is to analyze the effects of air pollutants on COPD hospitalizations in Lanzhou, China.Methods: An ecological time series study with distributed lag non-linear model (DLNM) was used for analysis. Daily COPD hospitalization data in Lanzhou from 1 January 2015 to 31 December 2019 were collected from 25 hospitals, as well as air pollutant data and meteorological data.Results: A total of 18,275 COPD hospitalizations were enrolled. For 10 μg/m3 increase in PM2.5, PM10, SO2, NO2, and 1 mg/m3 increase in CO at lag 07 day, the RR95%CI of COPD hospitalizations were 1.048 (1.030, 1.067), 1.008 (1.004, 1.013), 1.091 (1.048, 1.135), 1.043 (1.018, 1.068), and 1.160 (1.084, 1.242), respectively. The exposure–response curves between air pollutants (except O3-8h) and COPD hospitalizations were approximately linear with no thresholds. Female, and the harmful effect of PM on aged 3-8h) might increase the risk of COPD hospitalizations. O3-8h has a weak and unstable effect on COPD.Conclusion: Exposure to air pollutants (except O3-8h) increases the risk of COPD hospitalizations. O3-8h has a weak and unstable effect on COPD hospital admissions. The harmful effect of gaseous pollutants (except O3-8h) on COPD-hospitalized patients was stronger than that of PM.
- 19 September 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1399662
Open AccessThe effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015–2019)
Background: Lanzhou is the largest heavy industrial city in northwest China and it is a typical geographical valley-like city. However, there are few studies on the relationship between air pollutants and COPD, and their respective sample sizes are small, resulting in inconsistent results. The aim of this study is to analyze the effects of air pollutants on COPD hospitalizations in Lanzhou, China.Methods: An ecological time series study with distributed lag non-linear model (DLNM) was used for analysis. Daily COPD hospitalization data in Lanzhou from 1 January 2015 to 31 December 2019 were collected from 25 hospitals, as well as air pollutant data and meteorological data.Results: A total of 18,275 COPD hospitalizations were enrolled. For 10 μg/m3 increase in PM2.5, PM10, SO2, NO2, and 1 mg/m3 increase in CO at lag 07 day, the RR95%CI of COPD hospitalizations were 1.048 (1.030, 1.067), 1.008 (1.004, 1.013), 1.091 (1.048, 1.135), 1.043 (1.018, 1.068), and 1.160 (1.084, 1.242), respectively. The exposure–response curves between air pollutants (except O3-8h) and COPD hospitalizations were approximately linear with no thresholds. Female, and the harmful effect of PM on aged 3-8h) might increase the risk of COPD hospitalizations. O3-8h has a weak and unstable effect on COPD.Conclusion: Exposure to air pollutants (except O3-8h) increases the risk of COPD hospitalizations. O3-8h has a weak and unstable effect on COPD hospital admissions. The harmful effect of gaseous pollutants (except O3-8h) on COPD-hospitalized patients was stronger than that of PM.
- 18 September 2024
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 64, 229-235
Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study
- 18 September 2024
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 64, 229-235
Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study